WebMar 16, 2024 · Strata Oncology, Inc., ... bring the precision oncology advances we’ve seen in late-stage cancer to patients with early-stage disease,” said Dan Rhodes, Ph.D., co-founder and Chief Executive Officer, Strata Oncology. ... very soon after initial treatment which early-stage cancer patients are or are not destined for recurrence,” said ... WebJul 20, 2015 · Dan Rhodes CEO at Strata Oncology Ann Arbor, Michigan, United States 1K followers 500+ connections Join to view profile Strata …
Should We Sequence the DNA of Every Cancer Patient?
WebStrata Oncology will present at the 39th Annual J.P. Morgan Healthcare Conference, Wednesday, January 13, 2024, at 8:05 am ET. Our CEO Dan Rhodes will provide… WebOct 27, 2024 · StrataNGS, a PCR-CGP test, delivered reportable results in 93 percent of all samples received. "Medicare coverage of StrataNGS is an important milestone toward … north central conference ohio
Strata Oncology Completes $90 Million Series C Financing - PR …
WebView Daniel Rhodes's profile for company associations, background information, and partnerships. Search our database of over 100 million company and executive profiles. ... WebApr 10, 2024 · Strata, a precision oncology company, and UCSF are launching Stratify Prostate™, an initiative aimed at advancing precision medicine among men with advanced forms of the disease. “Our shared goal is to provide advanced patients the opportunity to be tested without the worry of cost or location,” Strata CEO Dan Rhodes, Ph.D., said in a ... WebOct 14, 2024 · Sponsored content brought to you by. Strata Oncology CEO and co-founder Dan Rhodes, PhD, describes how molecular testing of tumors as it exists today is insufficient to realize the full promise of precision cancer care, and how Strata has developed a new category of tests that provides comprehensive treatment selection … north central college web print